Search
for
Sort by
Research 361–390 of 1000+
- Non-motor Comorbidity of Myasthenia Gravis: Myasthenia Gravis as a Systemic Immunological Disorder Involving Non-motor Systems
- Severity grading of dermatological emergencies based on comorbidities and systemic involvement: An observational study
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- Drug History and SLE Laboratory Findings Among Iraqi Patients: A Hospital‐Based Study
- Managing Azathioprine-Induced Myelosuppression and Alopecia Totalis: Lessons from a SLE Patient
- Eosinophilic Pustular Folliculitis Involving Labial Mucosa, Which Improved with Naproxen
- Cutaneous Permeation and Penetration of Sunscreens: Formulation Strategies and In Vitro Methods
- Intralesional steroids for alopecia areata
- Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Efficacy and safety of methotrexate in alopecia areata
- Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9/MyD88 activation
- Case report: NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a young Chinese female with systematic lupus erythematosus: a case analysis and literature review
- LB1012 The development of a pediatric alopecia areata treatment classification system based on results from a systematic review
- PRP for Immune Mediated Alopecias (Alopecia Areata, Alopecia Totalis)
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
- Case of alemtuzumab-related alopecia areata management in MS
- S2608 A Rare Case of Iron Deficiency Anemia: Cronkhite-Canada Syndrome
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Alopecia Areata: Clinical Treatment
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Enhancing alopecia areata management: Nanocrystal-driven strategy for targeting hair follicles
- Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters
- Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- The Frontal Fibrosing Alopecia Treatment Dilemma